Replies to post #169 on Equity Field Notes from temporal sources

[DanWebzster]

APHB 's Science :

Bacteriophage undoubtedly work against bacterial disease and APHB is the only public company in the space.

APHB has survived so far by a combination of public funding and expanded access studies. The problem is whether management can come up with enough capital to run (a) pivotal study(ies).

Q1/18 Cash = $8.2mn while expenses totaled ~$5mn

In 2018 alone, APHB has announced cooperative programs with Veterans Administration, NIH and a government agency in Australia.

APHB is on my permanent watchlist for scalps and momentum technical patterns.